BIG PHARMA'S NOT THE CASH COW IT WAS—TIME FOR INVESTORS TO EXIT

Investor returns are on the line

BIG PHARMA OWNS NOTHING BUT PATENTS

In this article Taking Over Big Pharma Plants, we get a flavour for the scale of outsourcing Big Pharma had been cracking on with:

“AstraZeneca intends to outsource all its active pharmaceutical ingredient (API) production over the next five to seven years. Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co., and Pfizer are scaling back the number of their plants by up to 50% and are planning to outsource as much as 40% of their API needs.”

In another article, titled Pfizer to shed 400 UK jobs and sell off Morpeth plant, we hear of another sorry tale of tossing assets out the boat:

“The two locations in the UK have been identified in the review as having surplus capacity. Over the next few years, Sandwich in Kent is to shed 400 jobs, though Pfizer has said that the firm's research and development activities and some specialist production facilities would be retained at the plant. The former Pharmacia plant in Morpeth, Northumberland, which employs over 5…